Physician profile

Michael P Della Corte

Podiatrist · Maspeth, NY

NPI 1205812146

$5,969.30

in general payments reported to CMS, 2019-2025

16 companies · none reported in 2025

See the full distribution for Podiatrist

Payments by year

General payments by program year, as reported to CMS.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Royal Biologics, INC. $4,496.11 2019-2020
Stability Biologics, LLC $239.29 2021-2022
Orthofix Medical, INC. $212.70 2019
Baxter Healthcare $212.46 2019
Integra Lifesciences Corporation $162.49 2019
Organogenesis INC. $148.54 2019
Stryker Corporation $114.93 2019
Medline Industries LP $91.30 2019
Axogen $70.62 2019
Ortho Dermatologics, A Division of Bausch Health US, LLC $64.81 2019
Advanced Oxygen Therapy INC. $48.58 2019
Derma Sciences, INC. $29.67 2019
Smith+Nephew, INC. $29.37 2019
Wright Medical Technology, INC. $23.02 2019
Allergan, INC. $12.85 2019
Show all 16 companies
CompanyGeneral paymentsYearsTop products
Melinta Therapeutics, LLC $12.56 2019

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Michael P Della Corte

$5,969.30

in general payments reported 2019-2025

Years
2019-2022
Top company
Royal Biologics, INC.

https://glasscript.com/doctor/711228/michael-p-della-corte

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.